Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension-Reference-Cited by-同舟云学术

Adverse Prognostic Value of Persistent Office Blood Pressure Elevation in White Coat Hypertension

Published:2015-08 Issue:2 Volume:66 Page:437-444
ISSN:0194-911X
Container-title:Hypertension
language:en
Short-container-title:Hypertension

Author:

Mancia Giuseppe¹,Facchetti Rita¹,Grassi Guido¹,Bombelli Michele¹

Affiliation:

1. From the Department of Health Sciences (G.M., M.B., R.F., G.G.) and Clinica Medica (M.B., G.G.), University of Milano-Bicocca, Monza, Milan, Italy; IRCCS Istituto Auxologico Italiano, Milan, Italy (G.M.); and IRCCS Multimedica, Sesto San Giovanni, Milan, Italy (G.G.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Internal Medicine

Reference40 articles.

1. 2013 ESH/ESC Guidelines for the management of arterial hypertension

2. White-coat hypertension: misnomers, misconceptions and misunderstandings. What should we do next?

3. 'White coat' hypertension. No harm for the heart.

4. White-coat hypertension as a cause of cardiovascular dysfunction

5. White coat effect. Innocuous or adverse phenomenon?

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutoffs for white-coat and masked blood pressure effects: an ambulatory blood pressure monitoring study;Journal of Human Hypertension;2024-07-10

2. Hypertension paradox in Japan: the road ahead;Hypertension Research;2023-08-29

3. Possible cardiovascular risks of white coat hypertension: updated;Postgraduate Medicine;2023-05-10

4. Reproducibility and Predictive Value of White-Coat Hypertension in Young to Middle-Age Subjects;Diagnostics;2023-01-25

5. White Coat and Masked Hypertension;Pediatric Hypertension;2023